Form 8-K - Current report:
SEC Accession No. 0001193125-24-223282
Filing Date
2024-09-23
Accepted
2024-09-23 07:48:31
Documents
15
Period of Report
2024-09-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d845616d8k.htm   iXBRL 8-K 31488
2 EX-10.1 d845616dex101.htm EX-10.1 356540
3 EX-10.2 d845616dex102.htm EX-10.2 378022
  Complete submission text file 0001193125-24-223282.txt   1035281

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bcab-20240923.xsd EX-101.SCH 2850
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcab-20240923_lab.xml EX-101.LAB 17235
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcab-20240923_pre.xml EX-101.PRE 10812
17 EXTRACTED XBRL INSTANCE DOCUMENT d845616d8k_htm.xml XML 3492
Mailing Address 11085 TORREYANA ROAD SAN DIEGO CA 92121
Business Address 11085 TORREYANA ROAD SAN DIEGO CA 92121 858-558-0708
BioAtla, Inc. (Filer) CIK: 0001826892 (see all company filings)

EIN.: 851922320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39787 | Film No.: 241314647
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)